A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NBs / nuclear bodies

[Related PubMed/MEDLINE]
Total Number of Papers: 145
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NBs  (>> Co-occurring Abbreviation)
Long Form:   nuclear bodies
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Disruption of nuclear speckles reduces chromatin interactions in active compartments. NSs
2019 miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN. AML, APL, ATRA, miR-382-5p, NC
2019 PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery. HPV, PML, SUMO
2019 TGF-beta induces PML SUMOylation, degradation and PML nuclear body disruption. IFN, PML
2019 The SUMO Conjugation Complex Self-Assembles into Nuclear Bodies Independent of SIZ1 and COP1. COP1, SIZ1, SUMO
2018 A WW Domain-Containing Protein Forms Immune Nuclear Bodies against Begomoviruses. NIG, NSP
2018 Insight into nuclear body formation of phytochromes through stochastic modelling and experiment. ---
2018 Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. APL, HR, NHEJ, PML, RARalpha
2018 PML: Regulation and multifaceted function beyond tumor suppression. PML
10  2018 Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis. HSV-1, PML, TG, vDCP NBs
11  2018 Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation. IFN, PML
12  2018 Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy. EV71, PML
13  2018 Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells. MDM2, PML, PML-NB
14  2018 The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells. CP, HAPs, HBV, PML
15  2017 Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation. Ang II, ATO, hERG
16  2017 C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation. PML, SIM, SUMOs
17  2017 CACUL1/CAC1 attenuates p53 activity through PML post-translational modification. PML
18  2017 Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes. HPVs, PML, PML-NBs
19  2017 Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres. PML
20  2017 PML is a ROS sensor activating p53 upon oxidative stress. PML, ROS
21  2017 PML Nuclear Bodies Are Altered in Adult-Onset Neuronal Intranuclear Hyaline Inclusion Disease. NIHID, NIs, PML
22  2017 Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection. LLO, PML
23  2017 RNAi of arcRNA hsromega affects sub-cellular localization of Drosophila FUS to drive neurodiseases. arcRNA, dFUS, FUS, lncRNAs, RBPs, RNPs
24  2017 Specific genomic cues regulate Cajal body assembly. CB
25  2017 The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation. HCMV, IE1
26  2016 B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia. BLNK, PML
27  2016 PML isoform II plays a critical role in nuclear lipid droplet formation. LDs, NR, PML, PML-II
28  2016 The Sam68 nuclear body is composed of two RNase-sensitive substructures joined by the adaptor HNRNPL. arcRNA, RNase
29  2016 Translational control of PML contributes to TNFalpha-induced apoptosis of MCF7 breast cancer cells and decreased angiogenesis in HUVECs. ECs, IRES, MNK1, PML, TNF-alpha
30  2015 Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies. EBV, PML
31  2015 Cellular promyelocytic leukemia protein is an important dengue virus restriction factor. DENV, PML
32  2015 Comparative ultrastructure of CRM1-Nucleolar bodies (CNoBs), Intranucleolar bodies (INBs) and hybrid PML/p62 bodies uncovers new facets of nuclear body dynamic and diversity. CNoBs, IEM, INBs, LMB
33  2015 Distinct kinetics of DNA repair protein accumulation at DNA lesions and cell cycle-dependent formation of gammaH2AX- and NBS1-positive repair foci. IRIF
34  2015 Phase separation of a Lennard-Jones fluid interacting with a long, condensed polymer chain: implications for the nuclear body formation near chromosomes. LJ
35  2015 PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence. PML
36  2015 Systematic analysis of how phytochrome B dimerization determines its specificity. phyA
37  2015 TopBP1 is required at mitosis to reduce transmission of DNA damage to G1 daughter cells. ---
38  2014 Construction of synthetic nucleoli and what it tells us about propagation of sub-nuclear domains through cell division. ---
39  2014 Crowding-induced formation and structural alteration of nuclear compartments: insights from computer simulations. ---
40  2014 Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies. APL, HCC, HCV, IFNs, LT, PML
41  2014 Implication of PMLIV in both intrinsic and innate immunity. VSV
42  2014 Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins. PML, SIM
43  2014 PML control of cytokine signaling. PML
44  2014 PML nuclear bodies: regulation, function and therapeutic perspectives. ---
45  2014 PRMT1 arginine methyltransferase accumulates in cytoplasmic bodies that respond to selective inhibition and DNA damage. PRMTs
46  2014 The chicken adenovirus Gam1 protein, an inhibitor of the sumoylation pathway, partially complements ICP0-null mutant herpes simplex virus 1. HSV-1, PML
47  2014 The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence. ---
48  2013 A sequence in the Drosophila H3-H4 Promoter triggers histone locus body assembly and biosynthesis of replication-coupled histone mRNAs. HLB
49  2013 Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors. HUVECs, ISG-20, PML
50  2013 Hybrid detectors improved time-lapse confocal microscopy of PML and 53BP1 nuclear body colocalization in DNA lesions. HyDs
51  2013 PML nuclear bodies and SATB1 are associated with HLA class I expression in EBV+ Hodgkin lymphoma. cHL, PML, SATB1
52  2013 Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells. MHV-68, PML
53  2013 The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies. eIF3K, eIF3K-2, PML, PML-I
54  2012 Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. EBV, GC, PML
55  2012 Crowding effects on the formation and maintenance of nuclear bodies: insights from molecular-dynamics simulations of simple spherical model particles. LJ
56  2012 Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. EBV, PML, PMLIV
57  2012 Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. BRET, SIM
58  2012 Substitution of a conserved glycine in the PHR domain of Arabidopsis cryptochrome 1 confers a constitutive light response. COP, CRYs, PHR, SD
59  2012 The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1. HSV-1, PML
60  2011 Functional connection between Rad51 and PML in homology-directed repair. DSB, LT, PML, SV40
61  2011 Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. HCMV, IE1, MIE
62  2011 Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover. PML
63  2011 PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML. ALL, ATO, ChIP
64  2011 PML is a key component for the differentiation of myeloid progenitor cells to macrophages. BMMs, GMP, PML
65  2011 PML positively regulates interferon gamma signaling. IFN, ISGs, SUMO
66  2011 Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies. 3Dpol, EMCV, PML, SUMO
67  2011 Role of promyelocytic leukemia protein in host antiviral defense. IFN, PML, Sp100
68  2011 Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators. EBV, PML
69  2010 An integrative model for phytochrome B mediated photomorphogenesis: from protein dynamics to physiology. FRAP, phyB
70  2010 Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. EBV, NPC, PML
71  2010 N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies. PML, SUMO
72  2010 PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. APL, ROS
73  2010 Resistance to rabies virus infection conferred by the PMLIV isoform. SUMO, VSV
74  2010 SUMOylation promotes PML degradation during encephalomyocarditis virus infection. EMCV, PML
75  2009 A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells. PML, PML-NBs
76  2009 E6AP promotes the degradation of the PML tumor suppressor. PML
77  2009 Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells. BRET, PML, SBD, SUMO
78  2009 SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells. PML
79  2009 Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies. PML
80  2008 Dynamics of component exchange at PML nuclear bodies. ---
81  2008 Functional interaction of AIRE with PIAS1 in transcriptional regulation. SIM
82  2008 Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. HDAC7, HUVECs, PML
83  2008 Signal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies. HDAC, MEF2, MMP, PML, TNF
84  2007 Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies. CAV, PML, SUMO
85  2007 FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. FLASH
86  2007 Localization of interchromatin granule cluster and Cajal body components in oocyte nuclear bodies of the hemipterans. CBs, IGCs
87  2007 Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. PML, RA, SFs, SUMO
88  2006 Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. ---
89  2006 Intracellular localization of human ZBP1: Differential regulation by the Z-DNA binding domain, Zalpha, in splice variants. IFN, LMB, PODs
90  2006 SUMOylation substrates in neuronal intranuclear inclusion disease. HDAC4, NII, NIID, PML, SUMO-1
91  2006 The mechanisms of PML-nuclear body formation. ---
92  2005 Cooperative activation of transcription by autoimmune regulator AIRE and CBP. AIRE
93  2005 Identification and dynamics of Cajal bodies in relation to karyosphere formation in scorpionfly oocytes. CBs, Pol II
94  2005 PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction. IFN, PML, STAT1, TNF
95  2005 Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. APL
96  2005 Subcellular distribution of HP1 proteins is altered in ICF syndrome. ICF
97  2005 SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies. PML, SUMO-1
98  2005 [Karyosphere and extrachromosomal nuclear bodies in oocytes of the scorpionfly, Panorpa communis]. CBs
99  2004 A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. PML
100  2004 Do nuclear bodies in oocytes of Tenebrio molitor (Coleoptera: Polyphaga, Tenebrionidae) contain two forms of RNA polymerase II? CTD, mAb, Pol II